| Q37676243 | Advances in Non-Viral DNA Vectors for Gene Therapy |
| Q45887356 | Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy |
| Q34313548 | Cationic lipid-mediated transfection in vitro and in vivo (review). |
| Q41686157 | Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes |
| Q37340427 | Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction |
| Q40905791 | Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs |
| Q34143913 | Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells |
| Q37299072 | Designing heart performance by gene transfer. |
| Q34482187 | Development of non-viral vectors for systemic gene delivery |
| Q78176830 | Durable multitransgene expression in vivo using systemic, nonviral DNA delivery. |
| Q33613636 | Dysopsonin activity of serum DNA-binding proteins favorable for gene delivery |
| Q74099156 | Efficient naked plasmid cotransfection of lung grafts by extended lung/plasmid exposure time |
| Q34403680 | Gene delivery with synthetic (non viral) carriers. |
| Q45867740 | Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system |
| Q44636776 | In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome |
| Q38475411 | Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. |
| Q40359100 | Mechanistic studies of sequential injection of cationic liposome and plasmid DNA. |
| Q30479577 | Nanoprobes with near-infrared persistent luminescence for in vivo imaging. |
| Q36780064 | Nonviral gene delivery: what we know and what is next |
| Q37092309 | Pharmacokinetic considerations regarding non-viral cancer gene therapy |
| Q53893086 | Pharmacokinetics of plasmid DNA in the rat. |
| Q41985187 | Polyethylenimine-mediated gene delivery to the lung and therapeutic applications. |
| Q45883653 | Redirecting adenovirus to pulmonary endothelium by cationic liposomes |
| Q45872966 | Several serum proteins significantly decrease inflammatory response to lipid-based non-viral vectors |
| Q37611034 | Synthetic vehicles for DNA vaccination |
| Q48101020 | Systemic delivery of MicroRNA mimics with polyethylenimine elevates pulmonary microRNA levels, but lacks pulmonary selectivity. |
| Q37149082 | Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation |
| Q40710593 | The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. |
| Q44517522 | The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection |
| Q36293311 | Toxicity of cationic lipid-DNA complexes |
| Q34518719 | Vehicles for oligonucleotide delivery to tumours |